People · Operator
Named in public records as an officer, director or promoter · active 2010–2020 · Other, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| TerrAscend Corp. | — | Other | Series B | $135.5M | $356.9M | 2019 |
| Arbor Pharmaceuticals Inc | — | Pharmaceuticals | Series B | $22.0M | $592.2M | 2010 |
Jason Wild at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jason Wild on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Matthew Johnson | 1 | 9 |
| Todd Sone | 1 | 4 |
| Edward Schutter | 1 | 3 |
| Jason Ackerman | 1 | 3 |
| Allen Chao | 1 | 2 |
| Heather Molloy | 1 | 2 |
| John Donofrio | 1 | 2 |
| Craig Collard | 1 | 2 |
| Brian Feldman | 1 | 2 |
| Jarrett Disbrow | 1 | 2 |
| Lisa Swartzman | 1 | 1 |
| Michael Fedida | 1 | 1 |
| Joanna Halligan | 1 | 1 |
| Richard Mavrinac | 1 | 1 |
| Adam Kozak | 1 | 1 |
| Ari Unterman | 1 | 1 |
| Robyn Rabinovich | 1 | 1 |
| Stacey Schulte | 1 | 1 |
| Joshua Disbrow | 1 | 1 |
| Marianne Boskamp | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.